Page 8 - Cue Reader News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Accelerate Diagnostics (NASDAQ:AXDX – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Insider and Institutional Ownership 65.5% of Accelerate Diagnostics shares […]

Coherent (NASDAQ:COHR – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations. Earnings and Valuation This table compares Coherent and Cue […]

While most people are familiar with rapid at-home antigen tests, Cue Health, Detect, and Lucira Health all have FDA-authorized OTC molecular tests that combine PCR accuracy with the convenience of at-home antigen tests.

Cue Health (NASDAQ:HLTH – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, […]

Cue Health (NASDAQ:HLTH – Get Rating) and Codex DNA (NASDAQ:DNAY – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends. Profitability This table compares Cue Health and Codex DNA’s […]